Clinical trial
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
NCT00309101 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00309101 |
|---|---|
| Title | An Open Study for Steroid Resistant, Non-Thymectomized MG Patients |
| Official title | FK506 Phase 3 Study: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Myasthenia Gravis |
| Intervention type | Drug |
| Interventions | tacrolimus |
| Enrollment | 11 |
| Start date | Feb 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Mar 31, 2006 |
| Last update posted | Jun 3, 2009 |
| Countries | Japan |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: